A federal jury in Charleston, WV says that C.R. Bard is liable for flaws in some of the company’s transvaginal mesh implants, and they say the company needs to pay $2 million for its irresponsibility. Bloomberg.com is reporting on the trial, you can read their article on the verdict here.
The jury deliberated for about 12 hours before finding New Jersey-based Bard responsible for injuries to plaintiff Donna Cisson. The Georgia nurse was implanted with Bard’s Avaulta Plus transvaginal mesh back in 2009.
Cisson claimed that she suffered severe pain, bleeding, and bladder spasms before undergoing several surgeries to remove the mesh. During the trial, Cisson’s lawyers argued that Bard knew that the material used to make the mesh was not intended to be implanted in humans. They said that the company had placed profits before the safety of their patients.
Attorneys for Bard countered by claiming there was no intent to injure patients, and that the manufacturer complied with industry standards throughout the development and manufacturing of the mesh.
This is not the first time Cisson faced off against Bard in court: the first trial ended in a mistrial back in July.
The $2 million verdict includes $250,000 in compensatory damages and $1.75 million in punitive damages. Under Georgia law, 75% of the punitive damage judgment must go into the state’s general fund.
Bard vows to appeal the verdict.
Tucson personal injury lawyers have been watching this bellwether transvaginal mesh lawsuit to see how a jury would respond to the claims of a transvaginal mesh patient. There are still more than 8,000 cases pending against Bard, and if you have been injured by one of their products, it is important to contact a qualified Tucson transvaginal mesh attorney today.